EUVIMEDEUVIMED entdecken
Crossref

Risk Factors Associated with Incident Vertebral Fractures in Steroid-treated Males with Duchenne Muscular Dystrophy

Kim Phung iD, Laura McAdam, Jinhui Ma, Hugh J McMillan, Stefan Jackowski, Maya Scharke, Mary-Ann Matzinger, Nazih Shenouda, Khaldoun Koujok, Jacob L Jaremko, Nagwa Wilson, Scott Walker und 9 weitere

The Journal of Clinical Endocrinology & Metabolism · 2024

DOI: 10.1210/clinem/dgad435 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2024. Verfasst von Kim Phung und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Endocrinology, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, ON K1N 6N5, Canada. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne, Spinal Fractures, Fractures, Bone, Osteoporotic Fractures. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Clinical Research Fellowship, Parent Project Muscular Dystrophy, University of Ottawa.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Prevention of fractures is an unmet need in glucocorticoid (GC)-treated Duchenne muscular dystrophy. This study explored factors associated with incident vertebral fractures (VFs) to inform future fracture prevention efforts.

Methods

VFs were evaluated prospectively at study baseline and 12 months on lateral spine radiographs in participants aged 4 to 25 years with Duchenne muscular dystrophy. Clinical factors were analyzed for their association with the change in Spinal Deformity Index (sum of the Genant-defined VF grades from T4 to L4) between baseline and 12 months.

Results

Thirty-eight males were evaluated (mean ± SD age at baseline 11.0 ± 3.6 years; mean ± SD GC duration at baseline 4.1 ± 3.1 years; 74% ambulatory). Nine of 38 participants (24%) had 17 incident VFs, of which 3/17 VFs (18%) were moderate/severe. Participants with 12-month incident VF had lower mean ± SD baseline lumbar spine areal bone mineral density Z-scores (−2.9 ± 1.0 vs −1.9 ± 1.1; P = .049) and lower total body less head areal bone mineral density Z-scores (−3.1 ± 1.2 vs −1.6 ± 1.7; P = .036). Multivariable linear regression showed that at least 1 VF at baseline (P < .001), a higher number of antecedent non-VF (P < .001), and greater bone age delay at baseline (P = .027) were significant predictors of an increase in the Spinal Deformity Index from baseline to 12 months.

Conclusion

The observation that ≥ 1 prevalent VF and/or non-VF were the strongest predictors of incident VFs at 12 months supports the need for prevention of first fractures in this high-risk setting. Bone age delay, a marker of GC exposure, may assist in the prioritization of patients in efforts to prevent first fractures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscular Dystrophy, DuchenneSpinal FracturesFractures, BoneOsteoporotic FracturesMaleHumansBone DensityRisk FactorsGlucocorticoidsLumbar VertebraeSteroids

Stichwörter der Autor:innen

Duchenne muscular dystrophybone fragilityglucocorticoidsincident fracturesosteoporosisvertebral fractures

Substanzen

GlucocorticoidsSteroids

Autor:innen und Institutionen

  • Department of Pediatrics, Division of Endocrinology, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, ON K1N 6N5, Canada.
  • The Ottawa Pediatric Bone Health Research Group, Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON K1H 8L1, Canada.
  • Department of Pediatric, Division of Development, Holland Bloorview Kids Rehabilitation Hospital, Bloorview Research Institute, University of Toronto, Toronto, ON M5S 1A1, Canada.
  • Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON L8S 1L9, Canada.
  • Department of Pediatrics, Division of Neurology, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, ON K1H 8L1, Canada.
  • Department of Medical Imaging, University of Ottawa, Ottawa, ON K1N 6N5, Canada.

ORCID-Profile: Kim Phung, Leanne M Ward

Förderung

  • Clinical Research Fellowship
  • Parent Project Muscular Dystrophy
  • University of Ottawa
  • Children's Hospital of Eastern Ontario Research Institute

Zitieren

APA

Phung, K., McAdam, L., Ma, J., McMillan, H. J., Jackowski, S., Scharke, M., Matzinger, M. A., Shenouda, N., Koujok, K., Jaremko, J. L., Wilson, N., Walker, S., Hartigan, C., Khan, N., Page, M., Robinson, M. E., Saleh, D. S., Smit, K., Rauch, F., …, & Ward, L. M. (2024). Risk Factors Associated with Incident Vertebral Fractures in Steroid-treated Males with Duchenne Muscular Dystrophy. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgad435

Vancouver

Phung K, McAdam L, Ma J, McMillan HJ, Jackowski S, Scharke M, et al. Risk Factors Associated with Incident Vertebral Fractures in Steroid-treated Males with Duchenne Muscular Dystrophy. The Journal of Clinical Endocrinology & Metabolism. 2024. doi:10.1210/clinem/dgad435

BibTeX
@article{Phung2024,
  author = {Phung, Kim and McAdam, Laura and Ma, Jinhui and McMillan, Hugh J and Jackowski, Stefan and Scharke, Maya and Matzinger, Mary-Ann and Shenouda, Nazih and Koujok, Khaldoun and Jaremko, Jacob L and Wilson, Nagwa and Walker, Scott and Hartigan, Colleen and Khan, Nasrin and Page, Marika and Robinson, Marie-Eve and Saleh, David S and Smit, Kevin and Rauch, Frank and Siminoski, Kerry and Ward, Leanne M},
  title = {Risk Factors Associated with Incident Vertebral Fractures in Steroid-treated Males with Duchenne Muscular Dystrophy},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2024},
  doi = {10.1210/clinem/dgad435}
}
Kostenlos starten →